| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K Hanew, A Utsumi, A Sugawara, Y Shimizu, K Ab. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly. The Journal of clinical endocrinology and metabolism. vol 78. issue 3. 1994-04-12. PMID:8126120. |
plasma gh responses to gh-releasing peptide (ghrp) were studied in 11 patients with active acromegaly. |
1994-04-12 |
2023-08-12 |
Not clear |
| K Hanew, A Utsumi, A Sugawara, Y Shimizu, K Ab. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly. The Journal of clinical endocrinology and metabolism. vol 78. issue 3. 1994-04-12. PMID:8126120. |
it is concluded that ghrp stimulated gh release in the majority of acromegaly patients. |
1994-04-12 |
2023-08-12 |
Not clear |
| I A Rajkovic, E Valiontis, K K H. Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods. The Journal of clinical endocrinology and metabolism. vol 78. issue 3. 1994-04-12. PMID:8126156. |
serum samples were obtained from 21 subjects with gh deficiency, 24 patients with acromegaly, and 56 normal subjects; 12 of whom were postmenopausal women who were studied before and during oral estrogen treatment. |
1994-04-12 |
2023-08-12 |
human |
| H Watanobe, T Tamura, S Sasaki, K Takeb. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly. Neuropeptides. vol 25. issue 6. 1994-04-08. PMID:8127416. |
in this context, however, very little is known about the clinical significance of paradoxical gh responses to vasoactive intestinal peptide (vip) and lhrh in acromegaly. |
1994-04-08 |
2023-08-12 |
Not clear |
| H Watanobe, T Tamura, S Sasaki, K Takeb. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly. Neuropeptides. vol 25. issue 6. 1994-04-08. PMID:8127416. |
we therefore examined, as the principal objective of this study, whether a relationship exists among the gh (in some cases also prl) responses to trh, vip, lhrh and br in acromegaly. |
1994-04-08 |
2023-08-12 |
Not clear |
| H Watanobe, T Tamura, S Sasaki, K Takeb. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly. Neuropeptides. vol 25. issue 6. 1994-04-08. PMID:8127416. |
another aim of this study was to examine whether a sexual difference exists in gh and prl secretion in acromegaly. |
1994-04-08 |
2023-08-12 |
Not clear |
| H Watanobe, T Tamura, S Sasaki, K Takeb. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly. Neuropeptides. vol 25. issue 6. 1994-04-08. PMID:8127416. |
although this study is devoid of immunohistochemical evidence to support this hypothesis, we suggest that the present in vivo data may be of some help in understanding the basis of the great variabilities in the gh responses to various dynamic testings in acromegaly. |
1994-04-08 |
2023-08-12 |
Not clear |
| A J O'Sullivan, J J Kelly, D M Hoffman, J Freund, K K H. Body composition and energy expenditure in acromegaly. The Journal of clinical endocrinology and metabolism. vol 78. issue 2. 1994-03-23. PMID:8106626. |
we conclude from these observations in acromegaly that gh is a regulator of energy metabolism and body composition. |
1994-03-23 |
2023-08-12 |
human |
| A Giustina, M Doga, C Bodini, S Bossoni, E Bresciani, A R Buss. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly. Endocrine research. vol 19. issue 4. 1994-03-17. PMID:7508379. |
in acromegaly circulating gh levels are elevated and the gh response to ghrh may be exaggerated. |
1994-03-17 |
2023-08-12 |
human |
| A Giustina, M Doga, C Bodini, S Bossoni, E Bresciani, A R Buss. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly. Endocrine research. vol 19. issue 4. 1994-03-17. PMID:7508379. |
galanin has been recently shown to decrease circulating gh levels in acromegaly. |
1994-03-17 |
2023-08-12 |
human |
| A Giustina, M Doga, C Bodini, S Bossoni, E Bresciani, A R Buss. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly. Endocrine research. vol 19. issue 4. 1994-03-17. PMID:7508379. |
dopaminergic drugs were the only previously known agents able to cause a paradoxical gh fall in acromegaly. |
1994-03-17 |
2023-08-12 |
human |
| M H Lin, D Y Li. Measurements of urinary growth hormone in the assessment of its secretory status. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 92. issue 9. 1994-03-01. PMID:7904863. |
the 24-hour urinary gh excretion of seven children with complete gh deficiency was 1.90 +/- 1.55 ng/g cr (mean +/- sd), of 10 normal but short children was 19.04 +/- 14.11 ng/g cr, of 12 children with normal height was 14.57 +/- 5.53 ng/g cr, of 11 adults of normal height was 4.46 +/- 4.47 ng/g cr, and of six adults with acromegaly was 366.75 +/- 349.95 ng/g cr. |
1994-03-01 |
2023-08-12 |
Not clear |
| M H Lin, D Y Li. Measurements of urinary growth hormone in the assessment of its secretory status. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 92. issue 9. 1994-03-01. PMID:7904863. |
the nocturnal urinary gh excretion of seven children with complete gh deficiency was 2.27 +/- 1.22 ng/g cr, of 10 normal but short children was 22.74 +/- 12.76 ng/g cr, of 12 children of normal height was 22.40 +/- 11.86 ng/g cr, of 26 adults of normal height was 7.14 +/- 5.86 ng/g cr and of six adults with acromegaly was 338.70 +/- 309.12 ng/g cr. |
1994-03-01 |
2023-08-12 |
Not clear |
| M H Lin, D Y Li. Measurements of urinary growth hormone in the assessment of its secretory status. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 92. issue 9. 1994-03-01. PMID:7904863. |
there was no overlap in the urinary gh excretion, either 24-hour or nocturnal values, between children with complete gh deficiency and children without gh deficiency, or between adults with acromegaly and normal adults. |
1994-03-01 |
2023-08-12 |
Not clear |
| M H Lin, D Y Li. Measurements of urinary growth hormone in the assessment of its secretory status. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 92. issue 9. 1994-03-01. PMID:7904863. |
these data indicate that urinary gh measurements can reflect the endogenous gh secretory status and may be a promising tool for the diagnosis of complete gh deficiency in children and acromegaly in adults. |
1994-03-01 |
2023-08-12 |
Not clear |
| I Felix, S L Asa, K Kovacs, E Horvath, H S Smyt. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Archives of pathology & laboratory medicine. vol 118. issue 1. 1994-02-17. PMID:8285835. |
a 48-year-old man with visual disturbances and subtle features of acromegaly had elevated serum thyrotropin (thyroid-stimulating hormone) levels but was clinically euthyroid and initially had normal blood growth hormone (gh) levels. |
1994-02-17 |
2023-08-12 |
Not clear |
| M J Kayath, E M Russo, S A Dib, J G Vieir. Do impaired glucose tolerance and diabetes mellitus interfere with the interpretation of the growth hormone response to the oral glucose tolerance test? Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 25. issue 5. 1994-02-10. PMID:1342220. |
the ability of glucose to suppress growth hormone (gh) secretion is well known and the glucose test is widely used for the diagnosis of acromegaly. |
1994-02-10 |
2023-08-11 |
human |
| M J Kayath, E M Russo, S A Dib, J G Vieir. Do impaired glucose tolerance and diabetes mellitus interfere with the interpretation of the growth hormone response to the oral glucose tolerance test? Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 25. issue 5. 1994-02-10. PMID:1342220. |
however, when suspected acromegaly is associated with diabetes mellitus (dm) or impaired glucose tolerance (igt) the interpretation of the gh response to the oral glucose tolerance test (ogtt) may be difficult. |
1994-02-10 |
2023-08-11 |
human |
| P J Selman, J A Mol, G R Rutteman, E van Garderen, A Rijnber. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology. vol 134. issue 1. 1994-02-07. PMID:7506206. |
in the dog endogenous progesterone and synthetic progestins may incite overproduction of gh, resulting in acromegaly and insulin resistance. |
1994-02-07 |
2023-08-12 |
dog |
| K M Main, J Lindholm, M Vandeweghe, N E Skakkebae. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity. Acta endocrinologica. vol 129. issue 5. 1994-02-04. PMID:8279221. |
we therefore examined the diagnostic value of the measurement of urinary growth hormone (gh) excretion in seventy unselected patients with acromegaly of different activity by comparing it to serum gh, serum insulin-like growth factor i (igf-i) and clinical activity. |
1994-02-04 |
2023-08-12 |
Not clear |